Please provide your email address to receive an email when new articles are posted on . Increasing the dose interval of subcutaneous tocilizumab is associated with a lower chance of maintaining ...
WASHINGTON -- Freedom from relapse was maintained in multiple sclerosis patients on natalizumab (Tysabri) who received the infusion drug less frequently than the recommended 4-week interval, with ...
Tumor location, pathology, and patient ethnicity in the predictive accuracy of EUS in gastric and gastroesophageal junction cancers. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results